Results

Total Results: 1,760 records

Showing results for "refers".
Users also searched for: beers criteria

1. Quantitative Synthesis II: Interactive Quiz (ppt file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
   May 29, 2025 - Detection bias refers to systematic differences in outcome assessments among comparison groups. … Attrition bias refers to systematic differences among comparison groups in the loss of participants from

2. Quantitative Synthesis II: Interactive Quiz (ppt file)
   effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence-quiz.ppt
   May 29, 2025 - Detection bias refers to systematic differences in outcome assessments among comparison groups. … Attrition bias refers to systematic differences among comparison groups in the loss of participants from

3. Data Points 13: Use of Preoperative Breast MRI among older women with ductal carcinoma in situ and locally invasive breast cancer (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-mri-utilization_research.pdf
   August 01, 2012 - “Big Metro” refers to counties in metro areas with populations of at least 1 million. … “Metro” refers to other counties in metro areas. … “Urban” refers to coun- ties not in metro areas with at least 20,000 people. … “Less Urban” refers to counties with 2,500-19,999 people. … Rural refers to counties with fewer than 2,500 people.15 Tumor size: We defined tumor size using the

4. genetic-testing-developmental-disabilities-protocol-140930 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/genetic-testing-developmental-disabilities_research-protocol.pdf
   September 30, 2014 - Analytic validity refers to how accurately and reliably the test measures the analyte of interest, such … Analytic validity: simply refers to how well a test performs in the laboratory—how well does the test … Cross-reactivity: refers to the reaction that an assay may have with analytes other than the ones it … Diagnostic sensitivity: refers to the probability of a positive test result when disease is present. … Traceability: refers to a property of the result of a measurement or the value of a standard whereby

5. DRN: Report 1 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-safety_research.pdf
   July 01, 2009 - Refers to differences in access protocols (how to query the data) and programming languages. … Refers to databases with different structures or schemas. iv. Semantic heterogeneity. … Distribution. 33 While autonomy refers to the level of control over one’s data, distribution refers … Effectiveness refers to the ability to meet certain measureable goals. … Parsimony refers to the minimal transfer of data necessary to perform a given operation.

6. Cer-235-Pharma-Nonpharm-Ptsd-Update-Appendix-G-1 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharm-ptsd-update-appendix-g-1.xlsx
   May 29, 2025 - Overall Risk of Bias Rating Note: *"Domain" refers to the category or type of bias (e.g. … “Criteria” refers to each individual element used to assess each domain.

7. Effective Health Care (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0440_06-01-2011.pdf
   January 01, 2011 - )  A cancer survivor refers to an individual who has been diagnosed with cancer from their diagnosis

8. Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacological Interventions (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
   April 15, 2021 - The word “inception” presumably refers to the beginning of each database, but this could be made clearer … The text refers to nine trials and six observational studies. … Rather than using the vague term “trials”, it would be better to specify if this refers to randomized … It may be worth specifying that “disease severity” refers to the severity of the mental health disorder … The flow diagram refers to articles that were identified through text mining, yet the description of

9. Topic 0509 Home-based Primary Care Interventions NSD FINAL SJ-2 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0599-131115.pdf
   June 20, 2013 - )  Home-based primary care refers to models of care in which preventive or acute care is delivered

10. CER 210: Disposition of Comments for Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
    January 01, 2020 - We’re not sure what this comment refers to. … Comment refers to future sections as well. … Do we just assume that it refers to positive benefit? … We are not sure what this comment refers to. … Consistency refers to direction of effect.

11. Tools to (Semi) Automate Evidence Synthesis (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/AI-tools-protocol.pdf
    August 15, 2023 - Semi-automation refers to automation of some of the work while relying on humans to complete certain … Full automation refers to the ability of the computer to do all of the work (e.g., abstract screening

12. Making Sure That Evidence Is Understood and Used (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-making-sure-evidence-understood.pdf
    July 01, 2020 - Intervention or exposure: ◆ The “I” in PICO(TS) refers to the specific treatments or approaches with … It refers to short, intermediate, and long-term outcomes, and includes specific areas such as quality

13. AHRQ Slide Template 2009 (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence.ppt
    January 01, 2010 - Directness refers to the degree to which outcomes of interest to users of the comparative effectiveness … Applicability refers to the extent to which the trial data are likely to be applicable to populations … Performance bias refers to systematic differences in the care provided to participants in the comparison … Detection bias refers to systematic differences in outcome assessments among the comparison groups. … Attrition bias refers to systematic differences among comparison groups in the loss of participants from

14. AHRQ Slide Template 2009 (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence.ppt
    January 01, 2010 - Directness refers to the degree to which outcomes of interest to users of the comparative effectiveness … Applicability refers to the extent to which the trial data are likely to be applicable to populations … Performance bias refers to systematic differences in the care provided to participants in the comparison … Detection bias refers to systematic differences in outcome assessments among the comparison groups. … Attrition bias refers to systematic differences among comparison groups in the loss of participants from

15. Data Points 14: Use of Endocrine Therapy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-endocrine-therapy_research.pdf
    August 01, 2012 - Urban Continuum Codes from Economic Research Service (ERS), Department of Agri- culture.9 “Big Metro” refers … “Metro” refers to other counties in metro areas. … “Urban” refers to counties not in metro areas with at least 20,000 people. … “Less Urban” refers to counties with 2,500-19,999 people. … Rural refers to counties with fewer than 2,500 people.9 Tumor size: We defined tumor size using the

16. Disposition of Comments_Systematic Review_The Effect of Protein Intake on Health: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-protein-intake-disposition-comments.pdf
    November 22, 2024 - In this context, "inconclusive" refers to the lack of clear findings regarding the impact of dietary … It refers to the ongoing uncertainty regarding the impact of dietary protein intake on the risk of

17. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
    March 10, 2010 - The “4” refers to “4 years” which is a measure—current conventions require this to be numeric rather … The CER refers to risk reduction rather than prevention throughout the text. … This refers to our use of a simulation method to calculate number needed to treat or harm. … The comment about stroke refers to findings from the tibolone trial that was conducted in older women … The second row refers to DCIS specifically, this has been clarified.

18. Acs-Pci-Adjunctive-Devices Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-pci-adjunctive-devices_research-protocol.pdf
    July 01, 2010 - Consistency Consistency refers to the degree of similarity in the direction of the effect sizes from … Directness Directness refers to whether the evidence links the compared interventions directly with … Precision Precision refers to the degree of certainty surrounding an effect estimate with respect

19. PROPOSALS FOR A PHASED EVALUATION OF (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-tests-proposals_research.pdf
    January 01, 2009 - and the FDA’s phased approach in the clinical development of drugs and biologic products.21 Phase I refers … Phase II refers to clinical studies involving limited numbers of human subjects to gather preliminary … Phase III refers to controlled clinical studies intended to provide a reasonable assurance of safety … Finally, Phase IV refers to studies performed once a technology has gained marketing approval; these

20. PROPOSALS FOR A PHASED EVALUATION OF (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/whitepaper3-lijmer02262010-2.pdf
    January 01, 2009 - and the FDA’s phased approach in the clinical development of drugs and biologic products.21 Phase I refers … Phase II refers to clinical studies involving limited numbers of human subjects to gather preliminary … Phase III refers to controlled clinical studies intended to provide a reasonable assurance of safety … Finally, Phase IV refers to studies performed once a technology has gained marketing approval; these